Key result
Ticagrelor or enoxaparin reduces apoptosis versus saline in a rat model of ischemia-reperfusion lung injury.
Why the study?
The study was conducted to evaluate the potential protective effects of ticagrelor and enoxaparin pretreatment against ischemia-reperfusion-induced lung tissue injury in a rat model.
Does pretreatment with ticagrelor or enoxaparin reduce ischemia-reperfusion-induced lung injury in a rat model?
RCT
randomly divided
Does pretreatment with ticagrelor or enoxaparin reduce ischemia-reperfusion-induced lung injury in a rat model?
p-value: p=<0.001
Pretreatment with enoxaparin or ticagrelor ameliorates ischemia-reperfusion-induced lung injury in a rat model, with enoxaparin demonstrating superior anti-apoptotic effects.
Should not change clinical practice in lung IRI; leaves open translation of anti-apoptotic effects to human reperfusion injury.
OBJECTIVES: This study was conducted to reveal the possible protective effects of ticagrelor and enoxaparin pretreatment against ischemia-reperfusion (IR)-induced injury on the lung tissue of a rat model. METHODS: Wistar albino rats were randomly divided into 4 groups as follows: group-1 (control-sham), group-2 (control-saline+IR), group-3 (ticagrelor+IR), group-4 (enoxaparin+IR). Before the ischemic period, saline, ticagrelor, and enoxaparin were administered to the 2nd-4th groups, respectively. In these groups, IR injury was induced by clamping the aorta infrarenally for 2 h, followed by 4 h of reperfusion except group-1. After the rats were euthanized, the lungs were processed for histological examinations. Paraffin sections were stained with Haematoxylin&Eosin (H&E) for light microscopic observation. Apoptosis was evaluated by caspase-3 immunoreactivity. Data were statistically analyzed using the SPSS software. RESULTS: In the lung sections stained with H&E, a normal histological structure was observed in group-1, whereas disorganized epithelial cells, hemorrhage, and inflammatory cell infiltration were seen in the alveolar wall in group-2. The histologic structure of the treatment groups was better than that of group-2. Caspase-3(+) apoptotic cells were noticeable in sections of group-2 and were lower in the treatment groups. In group-4, caspase-3 immunostaining was lower than in group-3. In group-2, apoptotic cells were significantly higher than in the other groups (p<0.001). CONCLUSION: Based on the histological results, we suggested that both therapies ameliorated the detrimental effects of IR. Caspase-3 immunohistochemistry results also revealed that pre-treatment with enoxaparin gave better results in an IR-induced rat injury model. In further studies, other parameters such as ROS and inflammatory gene expressions should be evaluated for accurate results.
No takes yet. Share an insight, caveat, or question.
Fındık et al. (2019) conducted an RCT in Ischemia-reperfusion (IR)-induced injury. Ticagrelor and enoxaparin vs. Saline was evaluated on Apoptosis evaluated by caspase-3 immunoreactivity (p=<0.001). Pretreatment with ticagrelor or enoxaparin significantly reduced caspase-3(+) apoptotic cells compared to saline control in a rat model of ischemia-reperfusion lung injury (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: